AlphAIAlphAI — Financial news for AI agents
newspressnow.comAUG 312 min read$ALGN

Quentin Blackford to Join Align Technology Board of Directors

Align Technology (ALGN) announced Quentin Blackford, CEO of iRhythm Technologies, as a new board director. Andrea Saia will retire from the board on September 23, 2026.

Original reporting
newspressnow.com
Published Aug 31, 2026, 8:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 1, 2026, 2:54 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefCorporate actions
Primary signal
$ALGN
Neutral
high confidence
Mentioned
$ALGN
Relevance
6/10
AlphAI data visualization · based on newspressnow.com
Decision brief

The 30-second read

$ALGNNeutralLow
01

Why it matters

The appointment is a standard corporate governance update with modest strategic relevance.

02

Market read

Board change is a routine corporate action; investors may monitor for any shifts in strategic direction.

03

What to watch

Blackford's experience at iRhythm could bring new data‑analytics insights to Align's product roadmap.

Relevance 6/10Novelty 6/10Timing: effective immediately

Background

Align Technology is a leading provider of clear aligner orthodontics and intraoral scanning technology.

Company-level read

Ticker impact

$ALGNNeutralHigh confidence
Context

Quentin Blackford, CEO of iRhythm Technologies, appointed to Align Technology board, replacing retiring director Andrea Saia.

Expected impact

Modest upside potential if investors view the appointment as value‑adding; no immediate large move expected.

Evidence & confidence

Executive board changes are typically low‑impact but can influence long‑term governance and strategic initiatives.

Market effects

Sector

May signal continued focus on digital orthodontics and health‑tech integration within the dental device sector.

Regional

Limited to U.S. market; no broader regional effect.

Global

Minimal global impact beyond Align's shareholder base.

Counterpoint

What could challenge this read

Board addition may be seen as a cosmetic change with no material effect on earnings or growth.

Key entities

  • Executive
    Quentin Blackford

    President and CEO of iRhythm Technologies, now appointed to Align's board.

  • Director
    Andrea Saia

    Retiring board member of Align Technology.

Read at source← All news

Related articles

SEP 1
$ALGNLow

Align Tech adds Quentin Blackford to board

Align Technology (ALGN) added Quentin Blackford, CEO of iRhythm Technologies, to its board, expanding it to 11 members. Blackford brings healthcare and digital innovation experience. Director Andrea L. Saia will retire in September 2026, reducing the board to 10 members.

theglobeandmail.com1 min
AUG 27
$ALGNMed

Are Wall Street Analysts Bullish on Align Technology Stock?

Align Technology (ALGN), a medical device company, has underperformed the broader market and healthcare sector ETF over the past 52 weeks. Analysts expect its adjusted EPS to grow 10.9% YoY by 2026, with a consensus 'Moderate Buy' rating. The mean price target is $207.07, implying a 30.1% upside. Piper Sandler maintained a 'Buy' rating with a $235 target.

barchart.com2 min
AUG 12
$ALGNMed

Align Technology Prevails in China Patent Infringement Action Against Angelalign

Align Technology said a Jinan Intermediate People’s Court issued a first-instance ruling on Aug. 10, 2026 in a China patent case against Angel. The court found Angel’s MasterForce and ATreat systems infringe Align’s CN113693748B patent and ordered Angel to stop use, manufacturing, and sales, awarding RMB 10 million in damages. Angel can appeal to China’s Supreme People’s Court.

antaranews.com4 min
AUG 12
$ALGNMed

Align Technology, Inc.: Align Technology Prevails in China Patent Infringement Action Against Angelalign

Align Technology (Nasdaq: ALGN) said China’s Jinan Intermediate People’s Court ruled in its favor in a patent infringement case against Angelalign’s China subsidiaries. The court found Angel infringed Align’s CN113693748B patent tied to extraction-gap-closure technology, ordering a stop to use and sales in China and awarding RMB 10 million in damages. Angel can appeal.

finanznachrichten.de4 min
AUG 10
$DDDMed

3D Printing Financials: 3D Systems, Prodways, and Align Build on Positive Momentum - 3DPrint.com

3D Systems reported Q2 revenue of $94.6M, flat YoY, with healthcare up 6.8% and aerospace/defense and data center infrastructure each growing over 20%. Adjusted EBITDA loss narrowed to $0.8M. It expects Q3 revenue of $96M to $99M. Prodways posted Q2 revenue of €10.5M (+5% YoY) and plans a €20M buyback. Align Technology reported record Q2 revenue of just over $1.05B (+4.3%), with clear aligner revenue up 8.2% and 2026 revenue growth guidance of 3% to 4%.

3dprint.com6 min
AUG 8
$ALGNMedAI 9/10

Align Technology (ALGN) Q2 2026 Earnings Call Transcript

Align Technology (ALGN) reported Q2 2026 revenue of $1,056.2 million, up 4.3% y/y, driven by record Clear Aligner volumes and higher ASPs. Clear Aligner revenue rose 8.2% to $870.9 million on 691,785 cases. Systems and Services revenue fell 10.8% to $185.3 million. Q3 revenue guidance is $1.00 to $1.02 billion; full-year growth 3% to 4%.

aol.com7 min